COPD Trial, Recruiting NCT06858748 Sponsor: McMaster University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06858748
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older, of any gender
  • People with a moderate-to-severe asthma diagnosis confirmed by a lung specialist, with objective test results supporting the diagnosis (such as breathing tests showing reversibility or airway sensitivity)
  • People with a moderate-to-severe COPD diagnosis confirmed by a lung specialist, based on specific breathing test results, and who have a symptom score meeting a set threshold (confirm with trial site)
  • People with a persistent chronic cough lasting more than one year that has either not responded to treatment or has no identified cause, with a normal chest X-ray and no sign of airflow blockage on breathing tests
  • Healthy people with no history of lung or breathing conditions, no use of inhaled or steroid medications, normal lung function test results, and little to no breathing difficulty in daily life

Who may not be able to join:

  • People who are pregnant or breastfeeding
  • People who currently smoke, have smoked within the last 6 months, or have a significant smoking history (more than 10 pack-years)
  • People who have had a flare-up or worsening of their condition within the 4 weeks before joining
  • People who were born prematurely (at or before 36 weeks) or experienced complications around the time of birth
  • People with a history of other lung or breathing disorders beyond those listed above
  • People whose lung specialist suspects they may have a condition called primary ciliary dyskinesia
  • People currently taking mucus-thinning medications
  • People with memory, cognitive, or psychiatric difficulties that may affect their ability to participate fully
  • People currently receiving certain biologic (targeted antibody) treatments for conditions such as asthma — including specific medications that must have been stopped within a defined period before joining (confirm exact timeframes with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McMaster University
Registry
ClinicalTrials.gov
Start date
11 December 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Computed Tomography mucus score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov